Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)

Jiangsu Hengrui Medicine Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	395,049	310,587	316,838	277,811	396,571	702,753
Market Cap Growth	5.87%	-1.97%	14.05%	-29.95%	-43.57%	62.99%
Enterprise Value	369,427	286,905	298,159	258,198	375,624	684,268
PE Ratio	53.86	46.06	66.85	62.91	71.32	93.51
PS Ratio	12.62	10.43	12.60	11.55	12.47	21.34
PB Ratio	7.75	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	8.08	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	79.87	53.52	46.69	-	126.49	205.64
P/OCF Ratio	54.80	39.32	37.63	194.22	76.58	172.42
EV/Sales Ratio	11.62	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	43.44	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	48.29	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	74.69	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.02	0.02	0.01	-	0.06	-
Asset Turnover	0.60	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.71	1.64	1.50	1.44	1.80	1.98
Quick Ratio	9.38	8.62	10.74	7.36	7.72	6.70
Current Ratio	10.70	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	15.21%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.99%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Capital (ROIC)	9.74%	9.27%	6.45%	5.07%	7.07%	14.07%
Return on Capital Employed (ROCE)	14.70%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.86%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	1.25%	1.87%	2.14%	-0.30%	0.79%	0.49%
Payout Ratio	18.63%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	0.91%	-0.15%	1.20%	-0.36%	0.18%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.